Cargando…
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517485/ https://www.ncbi.nlm.nih.gov/pubmed/37742000 http://dx.doi.org/10.1186/s12931-023-02535-x |
| _version_ | 1785109332279427072 |
|---|---|
| author | Lo Cicero, Stefania Castelli, Germana Blaconà, Giovanna Bruno, Sabina Maria Sette, Giovanni Pigliucci, Riccardo Villella, Valeria Rachela Esposito, Speranza Zollo, Immacolata Spadaro, Francesca De Maria, Ruggero Biffoni, Mauro Cimino, Giuseppe Amato, Felice Lucarelli, Marco Eramo, Adriana |
| author_facet | Lo Cicero, Stefania Castelli, Germana Blaconà, Giovanna Bruno, Sabina Maria Sette, Giovanni Pigliucci, Riccardo Villella, Valeria Rachela Esposito, Speranza Zollo, Immacolata Spadaro, Francesca De Maria, Ruggero Biffoni, Mauro Cimino, Giuseppe Amato, Felice Lucarelli, Marco Eramo, Adriana |
| author_sort | Lo Cicero, Stefania |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10517485 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105174852023-09-24 Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients Lo Cicero, Stefania Castelli, Germana Blaconà, Giovanna Bruno, Sabina Maria Sette, Giovanni Pigliucci, Riccardo Villella, Valeria Rachela Esposito, Speranza Zollo, Immacolata Spadaro, Francesca De Maria, Ruggero Biffoni, Mauro Cimino, Giuseppe Amato, Felice Lucarelli, Marco Eramo, Adriana Respir Res Correction BioMed Central 2023-09-23 2023 /pmc/articles/PMC10517485/ /pubmed/37742000 http://dx.doi.org/10.1186/s12931-023-02535-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Lo Cicero, Stefania Castelli, Germana Blaconà, Giovanna Bruno, Sabina Maria Sette, Giovanni Pigliucci, Riccardo Villella, Valeria Rachela Esposito, Speranza Zollo, Immacolata Spadaro, Francesca De Maria, Ruggero Biffoni, Mauro Cimino, Giuseppe Amato, Felice Lucarelli, Marco Eramo, Adriana Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients |
| title | Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients |
| title_full | Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients |
| title_fullStr | Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients |
| title_full_unstemmed | Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients |
| title_short | Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients |
| title_sort | correction to: l1077p cftr pathogenic variant function rescue by elexacaftor–tezacaftor–ivacaftor in cystic fbrosis patient-derived air–liquid interface (ali) cultures and organoids: in vitro guided personalized therapy of non-f508del patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517485/ https://www.ncbi.nlm.nih.gov/pubmed/37742000 http://dx.doi.org/10.1186/s12931-023-02535-x |
| work_keys_str_mv | AT locicerostefania correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT castelligermana correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT blaconagiovanna correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT brunosabinamaria correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT settegiovanni correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT pigliucciriccardo correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT villellavaleriarachela correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT espositosperanza correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT zolloimmacolata correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT spadarofrancesca correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT demariaruggero correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT biffonimauro correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT ciminogiuseppe correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT amatofelice correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT lucarellimarco correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients AT eramoadriana correctiontol1077pcftrpathogenicvariantfunctionrescuebyelexacaftortezacaftorivacaftorincysticfbrosispatientderivedairliquidinterfacealiculturesandorganoidsinvitroguidedpersonalizedtherapyofnonf508delpatients |